“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Create an account and get access to all information about Axsome Therapeutics, Inc
No Credit card required. Free Credit
No Credit card required. It’s fast, easy, and FREE! 🛠️
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
About
Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are intensely committed to developing products that meaningfully improve the lives of patients and provide additional therapeutic options for physicians
| C-Level 2 | VP - Level9 |
| Director128 | Manager257 |
| Others142 | |
| Structure | Email Format |
|---|---|
| <f><last>@ |
|
| Pain Points | Locations | Technologies |
|---|---|---|
| Application Development | Buffalo, NY | communication, e |
| Application Development | Columbus, OH | communication, e |
| Application Development | New York, NY | integrity, assessment, payment, analytics, communication, forecasting, data query, audit, data analysis, compliance, lms, r, procedure, operations, financial, e, sas, risk, data management, collaboration, sox |
| BI | Buffalo, NY | communication, e |
| BI | Columbus, OH | communication, e |
Axsome Therapeutics, Inc looking to hire in Account Payable in Field, British Columbia, Canada
Axsome Therapeutics, Inc looking to hire in Account Payable in Eugene, OR
Axsome Therapeutics, Inc looking to hire in Account Payable in New York City Metropolitan Area
Amazon connect
Atlassian jira
Gcp
Google analytics
Access
Agile
Release management
Acceptance testing
Ai-driven
Analytics
Axsome Therapeutics, Inc. is a biopharmaceutical company developing and delivering novel therapie...
View MoreAxsome Therapeutics, Inc. is a biopharmaceutical company developing and delivering novel therapie...
View MoreAxsome Therapeutics, Inc. is a biopharmaceutical company developing and delivering novel therapie...
View MoreAxsome Therapeutics, Inc. is a biopharmaceutical company developing and delivering novel therapie...
View MoreAxsome Therapeutics, Inc. is a biopharmaceutical company developing and delivering novel therapie...
View MoreAxsome Therapeutics, Inc. is a biopharmaceutical company developing and delivering novel therapie...
View MoreOn Wednesday, 17 September 2025, Axsome Therapeutics (NASDAQ:AXSM) participated in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy
Read MoreAxsome Therapeutics (AXSM) operates in a high-stakes arena: specialty pharma, where blockbuster drugs face relentless pressure from generic competitors.
Read MoreAxsome Therapeutics has a positive outlook despite a generic challenge to its drug SYMBRAVO. Analyst Ram Selvaraju at H.C. Wainwright believes the drug's
Read MoreH.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Axsome Therapeutics today and set a price target of $180.00. Ram Selvaraju's rating is
Read MoreAxsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are intensely committed to developing products that meaningfully improve the lives of patients and provide additional therapeutic options for physicians
Biopharmaceuticals;pain;cns;narcolepsy;major depressive disorder;alzheimer's disease agitation;fibromyalgia;smoking cessation;migraine;attention deficit hyperactivity disorder
Axsome therapeutics, inc operates in the Biotechnology research industry.
Axsome therapeutics, inc's revenue is $385.69m
Axsome therapeutics, inc has 501 - 1000 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.